PACS Group is the skilled-nursing consolidator that spent last year repairing an accounting crisis and is now asking the market to treat the franchise as a compounding operator again. The second-quarter story is not a new-deal print. Existing facilities carried the earnings, occupancy stayed well above the industry average, and management raised the full-year outlook even while leaving most of the Eduro Healthcare book and the entire Florida package out of guidance. That combination is why the equity has re-rated from a distressed handle toward a peer-like earnings multiple.
The tension sits in what that multiple already assumes. A restatement of Medicare Part B respiratory and therapy revenue, delinquent filings, and still-open Justice Department and securities-regulator probes are why shares once traded near a single-digit handle. Those items have not disappeared. What has changed is the operating evidence. Same-store skilled nursing revenue rose 5.8 percent. Overall occupancy reached 90.4 percent. Adjusted earnings before interest, taxes, depreciation, and amortization grew to $166.8 million. The ramping cohort, not the mature book, is doing the mix work.
The next year resolves whether that occupancy engine still works on dirtier vintages. Twenty Eduro Texas buildings closed in August at mid-sixties occupancy and a skilled mix near ten percent. A thirty-two facility Florida lease from Omega Healthcare Investors is signed for a fourth-quarter close. Guidance now calls for revenue of $5.75 billion to $5.85 billion. Adjusted earnings before interest, taxes, depreciation, and amortization sit at $640 million to $660 million. The debate is whether a mid-twenties trailing earnings multiple already pays for a clean legal outcome and a successful ramp, or whether the market is still underestimating the conversion of those new books.